Home / Posts Tagged "medical marijuana"

Tag: medical marijuana

VIDEO: CanniMed Therapeutics Inc CEO Responds to Hostile Takeover Bid From Aurora Cannabis Inc.

Brent Zettl CEO of CanniMed Therapeutics Inc (TSE: CMED, OTCMKTS: CMMDF, FRA: 0GB) , talks to James about the hostile takeover threat which is in-progress from Aurora Cannabis Inc (TSE:ACB,OTCMKTS: ACBFF) .  Brent shares his side of the story and argues why his shareholders should stay with the company and not tender their shares to Aurora.  He also discusses CanniMed’s interest in Newstrike Resources Ltd (CVE: HIP, OTCMKTS: NWKRF, FRA: 0N8), and how that could affect this volatile situation.   TRANSCRIPT: James […]

VIDEO: CannTrust Holdings Inc. President Talks About Their Exponential Growth in New Cannabis Patients

Brad Rogers, President & COO of CannTrust Holdings Inc. (CNSX: TRST), an ACMPR Licensed Medical Marijuana Producer, talks about their ability to acquire 1000+ new patients per week in their latest run.  They have also announced their expansion plans which will increase their footprint in Ontario significantly.   TRANSCRIPT: James West:    Hey Brad, thanks for joining us today. Brad Rogers:   Thank you for having me. James West:    Brad, you’ve had a stellar quarter; you’ve closed a $20 million financing. Let’s […]

VIDEO: Canopy Growth CEO Bruce Linton Discusses Rec Cannabis in Canada

Canopy Growth Corp (TSX:WEED) CEO Bruce Linton is never short on things to say about Canada’s cannabis sector, and in this interview, he pulls no punches in his disdain for Canadian companies with US marijuana assets, or for anybody who thinks they can get in Canopy’s way. TRANSCRIPT: James West:     Bruce, welcome back – thanks for joining me again. Bruce Linton:     Thank you. James West:     Bruce, let’s talk about the market in general. First of all, your market cap’s now […]

InMed President and CEO Eric Adams on the Future of Treating Disease with Cannabinoids

  InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) (FRA:MWG2) performs research on extracted and purified cannabinoids to treat severe disease. President and CEO Eric Adams talks to James about the Canadian cannabinoid market, patenting, and their research on oils to treat a rare skin disorder often first seen on children.   TRANSCRIPT: James West:     Eric, thanks for joining me today. Eric Adams:     Thanks for having me. James West:     Eric, why don’t you give me an overview: what is it that InMed does? […]

New Cannabis Ventures and 420Investor CFA Alan Brockstein joins to talk about the emerging opportunities in the Cannabis space, and how investors need to watch out as the darker underbelly of capital markets are attracted to the rich valuations currently being experienced in certain issuers.

Flawed Bill C-45 Could Defeat Canadian Cannabis Legislation’s Good Intentions

Within the text of Bill C-45 The Cannabis Act are sown the seeds for the program’s potential failure. The Liberal Government has limited time to change course and avoid both a price war and a flood of constitutional challenges. The legislation is built on what superficially could be interpreted as contradictory targeted outcomes, and faulty assumptions. The summary of Bill C-45’s first reading states “The objectives of the Act are to prevent young persons from accessing cannabis, to protect public health and public safety by […]

VIDEO: Canopy Growth Corp President Mark Zekulin Talks the Future

  Canopy Growth Corp (TSE:WEED) is the world’s largest legal marijuana growing operation, with a combined total of well over a million square feet of growing capacity across multiple locations throughout Ontario and Saskatchewan. Canopy president Mark Zekulin sheds light on how he sees the future of Canopy in the cannabis industry with the onset of legalization of cannabis consumption for recreational purposes, which by all accounts is on track for taking effect on July 1st, 2018.

MedReleaf Corp (TSE:LEAF) (OTCMKTS:MEDFF) CEO Neil Closner makes no bones about the fact that his company's marijuana is the highest quality available in Canada. With an impressive depth of knowledge in the space, and as the country's only "significantly profitable" ACMPR grower, Neil illuminates the reasons for that positioning, and the company's plans to capture recreational market share.

MedReleaf Corp CEO Neil Closner on Growing “The Best” Marijuana in Canada Copy

The value proposition is that we happen to be a producer of the highest quality cannabis, we believe, in Canada. When I say ‘we believe’ that’s validated by the fact that patients, by and large, are purchasing products from us that are at a higher price than the average market price, which seems to be a validation point on the quality of our products.

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!